Soligenix Announces $600,000 Subaward Supporting Evaluation of Innate Defense Regulator Platform Technology as a Medical Countermeasure for Bacterial Threat Agents - PRNewswire

Soligenix Announces $600,000 Subaward Supporting Evaluation of Innate Defense Regulator Platform Technology as a Medical Countermeasure for Bacterial Threat Agents  PRNewswire

PRINCETON, N.J., May 28, 2019 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused ...



Comments

Popular posts from this blog

Common Questions About Vaccines (for Parents) | Nemours KidsHealth

GROWING PROBLEM Botched penis enlargement epidemic hits Papua New Guinea as docs warn 500 have injected todgers with coconut oil - Information-Analytic Agency NEWS.am